Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Curly Morris

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Experimental Hematology|August 30, 2008
Assessment of the role of timing of second transplantation in multiple myeloma by multistate modelingSimona Iacobelli, Jane Apperley, Curly Morris
Leukemia & Lymphoma|June 30, 2004
Routine analysis of IgVH mutational status in CLL patients using BIOMED-2 standardized primers and protocolsChristine Matthews, Mark Catherwood, T C M 'Curly' Morris, et al.
Leukemia Research|May 23, 2006
V(H)3-48 and V(H)3-53, as well as V(H)3-21, gene rearrangements define unique subgroups in CLL and are associated with biased lambda light chain restriction, homologous LCDR3 sequences and poor prognosisChristine Matthews, Mark A Catherwood, T C M 'curly' Morris, et al.
Haematologica|July 6, 2005
Detection of tumor-derived antigen receptor DNA by polymerase chain reaction in the serum of patients with B-cell chronic lymphocytic leukemiaMark A Catherwood, J Paul Wall, T C M Curly Morris, et al.
Leukemia & Lymphoma|April 10, 2008
Mutated IgHV1-69 gene usage represents a distinct subgroup associated with indolent disease in chronic lymphocytic leukemiaLeeona Galligan, Mark A Catherwood, Christine Matthews, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 18, 2020
Are Autologous Stem Cell Transplants Still Required to Treat Myeloma in the Era of Novel Therapies? A Review from the Chronic Malignancies Working Party of the EBMTLaurent Garderet, Curly Morris, Meral Beksac, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 13, 2017
Response Assessment in Myeloma: Practical Manual on Consistent Reporting in an Era of Dramatic Therapeutic AdvancesLaurent Garderet, Anita D'Souza, Paulette Jacobs, et al.
Leukemia & Lymphoma|November 17, 2006
MDR-1, but not MDR-3 gene expression, is associated with unmutated IgVH genes and poor prognosis chromosomal aberrations in chronic lymphocytic leukemiaChristine Matthews, Mark A Catherwood, Anne-Marie Larkin, et al.
Haematologica|May 6, 2010
Primary plasma cell leukemia and autologous stem cell transplantationMary B Drake, Simona Iacobelli, Anja van Biezen, et al.
Leukemia & Lymphoma|September 14, 2004
Aggressive natural killer cell leukemia/lymphoma: case report, use of telesynergy and review of the literatureJoanne Murdock, Elaine S Jaffe, Wyndham H Wilson, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Experimental Hematology|August 30, 2008
Assessment of the role of timing of second transplantation in multiple myeloma by multistate modelingSimona Iacobelli, Jane Apperley, Curly Morris
Leukemia & Lymphoma|June 30, 2004
Routine analysis of IgVH mutational status in CLL patients using BIOMED-2 standardized primers and protocolsChristine Matthews, Mark Catherwood, T C M 'Curly' Morris, et al.
Leukemia Research|May 23, 2006
V(H)3-48 and V(H)3-53, as well as V(H)3-21, gene rearrangements define unique subgroups in CLL and are associated with biased lambda light chain restriction, homologous LCDR3 sequences and poor prognosisChristine Matthews, Mark A Catherwood, T C M 'curly' Morris, et al.
Haematologica|July 6, 2005
Detection of tumor-derived antigen receptor DNA by polymerase chain reaction in the serum of patients with B-cell chronic lymphocytic leukemiaMark A Catherwood, J Paul Wall, T C M Curly Morris, et al.
Leukemia & Lymphoma|April 10, 2008
Mutated IgHV1-69 gene usage represents a distinct subgroup associated with indolent disease in chronic lymphocytic leukemiaLeeona Galligan, Mark A Catherwood, Christine Matthews, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 18, 2020
Are Autologous Stem Cell Transplants Still Required to Treat Myeloma in the Era of Novel Therapies? A Review from the Chronic Malignancies Working Party of the EBMTLaurent Garderet, Curly Morris, Meral Beksac, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 13, 2017
Response Assessment in Myeloma: Practical Manual on Consistent Reporting in an Era of Dramatic Therapeutic AdvancesLaurent Garderet, Anita D'Souza, Paulette Jacobs, et al.
Leukemia & Lymphoma|November 17, 2006
MDR-1, but not MDR-3 gene expression, is associated with unmutated IgVH genes and poor prognosis chromosomal aberrations in chronic lymphocytic leukemiaChristine Matthews, Mark A Catherwood, Anne-Marie Larkin, et al.
Haematologica|May 6, 2010
Primary plasma cell leukemia and autologous stem cell transplantationMary B Drake, Simona Iacobelli, Anja van Biezen, et al.
Leukemia & Lymphoma|September 14, 2004
Aggressive natural killer cell leukemia/lymphoma: case report, use of telesynergy and review of the literatureJoanne Murdock, Elaine S Jaffe, Wyndham H Wilson, et al.
Pageof 4